Strategic Advice and Regulatory Analysis

BlueReg experienced consultants can provide insight into all regulatory requirements for France:

  • Drug Registration
  • Early Access Programmes
  • Post Marketing Authorisation Application (MAA) activities
  • Promotional material review
  • Quality systems and audits
  • Interactions with healthcare professionals includingcompliance with the French laws (DMOS, Transparence de liens, Charte de lā€™information promotionnelle)
  • Pharmacovigilance
  • Pricing and reimbursement

Our experts

Associated News

The French system for preventing and managing shortages

The French regulation on the prevention and management of stock shortages of medicinal products is...

Learn more